YouTube Facebook LinkedIn Google+ Twitter Xinginstagram rss  

News Blast

Nov 15, 2005

Invitrogen announced the acquisitions of Quantum Dot Corp. and the BioPixels business unit of BioCrystal Ltd. and the early closing of the Biosource International acquisition. The acquisitions bolster Invitrogen’s molecular probes business in advanced labeling and detection technologies, the company says.

CombinatoRx and Angiotech Pharmaceuticals announced a multi-year research and license agreement for the discovery, development, and potential commercialization by Angiotech of drug devices and interventional medicine products built from innovative drug combinations. The initial focus is on vascular, orthopedic, and general surgery indications.

Caliper Life Sciences announced the closing of its planned acquisition for $22 million of NovaScreen BioSciences. The acquisition combines NovaScreen’s screening, profiling, and assay development services with Caliper’s LabChip and liquid handling products.

Rosetta Biosoftware and Agendia will work together to deliver novel diagnostics tools that will be made available in the Rosetta Resolver system for gene expression data analysis.

View Next Related Story
May New Products | May 27, 2016
Click here to login and leave a comment.  


Add Comment

Text Only 2000 character limit

Page 1 of 1

For reprints and/or copyright permission, please contact Angela Parsons, 781.972.5467.